Recent Reports


2010-01-25: Medical Research, Diagnostic Substances, Life Science Tools Report
7 leading Analysts; and top management from 2 Sector Firms examine this vital industry in this 38 page report from The Wall Street Transcript.
More Information
Order this Report

2009-12-07: Consumer Health Services Report
7 leading Analysts; and top management from 2 Sector Firm examine this vital industry in this 53 page report from The Wall Street Transcript.
More Information
Order this Report

2009-11-02: Pharmaceuticals Report
3 leading Analysts; and top management from 16 Sector Firms examine this vital industry in this 76 page report from The Wall Street Transcript.
More Information
Order this Report

2009-10-19: Biotechnology Report
3 leading Analysts; 2 Money Managers; and top management from 12 Sector Firms examine this vital industry in this 70 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Real Estate: Healthcare REITs, Long-Term Care Facilities & Hospitals Report
3 analysts and 6 sector firms examine the medical real estate segment in this 45 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Devices Report
4 analysts and 7 sector firms examine the medical devices segment in this 41 page report from The Wall Street Transcript.
More Information
Order this Report

09.14.09: Medical Research Services Report
2 analysts, and 4 sector firms examine the medical research services segment in this 23 page report from The Wall Street Transcript.
More Information
Order this Report

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Analyst Interview Excerpt
SCREENING THE MEDICAL DEVICES SECTOR – MATT MIKSIC – PIPER JAFFRAY & CO.


Full article published: 09/21/2009


For Subscribers

Get this article online now!

Order just this article
TWST: What segment of the medical devices sector do you cover, and which companies specifically you cover?
Mr. Miksic: The model at Piper is a little bit different. We have four senior analyst teams covering medical devices, with some specializing more in cardio, another in diagnostics, or diabetes and women's health. I cover a mix of large- cap and small-cap medical technology and hospital supply stocks spanning orthopedics, spine and ophthalmology, as well as small-cap and large-cap diversified hospital supply companies like J&J (JNJ) and Baxter (BAX). It's a diverse group and a lot of ground to cover, which keeps things interesting.

TWST: Would you give a couple of the names?
Mr. Miksic: For orthopedics, we cover Smith & Nephew (SN.L), Stryker (SYK), Zimmer (ZMH), Wright Medical (WMGI) and Symmetry (SMA), which is really a manufacturing partner to most of the implant providers. In spine, we cover NuVasive (NUVA), TranS1 (TSON) and Integra LifeSciences (IART), which is just breaking into the spinal fusion market in a more direct and significant way over the past 12 to 18 months. Names that I would include in the hospital supply category include Baxter, J&J, Kinetic Concepts (KCI) and CONMED (CNMD). In the micro-cap or emerging growth area we cover a small robotics orthopedic player called MAKO (MAKO), which I think has differentiated technology in orthopedics and robotics. In ophthalmology we cover Alcon (ACL).

 

Tickers included in this excerpt: BAX, IART, JNJ, NUVA, SN.L, SYK, TSON, WMGI, ZMH

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.